hotspot -WSS

hotspot

author：entertainment 2025-08-29 01:53:34 - browse：926

Two researchers look at a projection screen displaying medical devices, scientific graphs and DNA — health tech coverage from STAT — Adobe

The federal government’s plan to boost its oversight of the use of artificial intelligence tools in health care drew censure from startups arguing that overregulation stifles new ideas. But as Washington forges ahead, founders say they’re in the dark about who will be regulated and how — and they’re urging policymakers to offer clarity.

As they race for a slice of the $4 trillion U.S. health care market, AI founders and investors say regulatory uncertainty is a hurdle, forcing them to build more slowly and meticulously document for fear of potential audits. That makes it harder to keep up with the tech industry’s breakneck pace, they tell STAT.

The regulatory uncertainty adds to the many challenges dogging young health tech ventures today: Last year investments in digital health startups shriveled to their lowest annual total since 2019, and leaders are desperate to preserve what little funds they have, including through layoffs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Solve the antibiotic resistance crisis with preventive drugs

hotspot

WSS

Brain 'hot spot' may explain why African Americans feel greater pain

Option Care buys Amedisys in $3.6 billion home care deal

Can food be medicine? And other questions about a new push

UnitedHealth’s board chair also owns a personal investment firm

Make 'food is medicine' a key part of White House nutrition meeting

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

entertainment

hotspot

knowledge

Walensky prepares to leave CDC — and Congress — behind

Can food be medicine? And other questions about a new push

Dobbs anniversary: the lost opportunity of abortion as health care

Van's Gluten Free Original Waffles recalled for possible wheat allergen

The high cost of giving birth even with insurance

Grail is spending more than ever lobbying Congress

BioMarin wins approval for gene therapy to treat hemophilia A

First Opinion Podcast: Long Covid needs a new approach

Guidelines to prevent youth baseball injuries need more muscle

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

explore

Medicare reduced heart disease by changing how it pays doctors

Community addresses injustice for Long Island mothers

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Solve the antibiotic resistance crisis with preventive drugs

Meta looks to target Twitter with a rival app called Threads

Listen: Biogen's messy board & Laronde's data problem

focus

hotspot

leisure time

hotspot